BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13) (Middle Region) Peptide
BCL2L13
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits BCL2L13
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
- Protein Region
- Middle Region
- Origine
- Humain
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-BCL2L13 antibody (Catalog #: AVARP02032_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
- Synonymes
- si:ch211-238n5.7 Peptide, Mil1 Peptide, BCL-RAMBO Peptide, Bcl2-L-13 Peptide, MIL1 Peptide, E430016C20Rik Peptide, Mil-1 Peptide, BCL2 like 13 Peptide, BCL2-like 13 (apoptosis facilitator) Peptide, BCL2L13 Peptide, bcl2l13 Peptide, Bcl2l13 Peptide
- Sujet
-
BCL2L13 May promote the activation of caspase-3 and apoptosis.
Alias Symbols: BCL-RAMBO, MIL1, Bcl2-L-13
Protein Interaction Partner: GABARAPL2,GABARAPL2
Protein Size: 485 - Poids moléculaire
- 53 kDa
- ID gène
- 23786
- NCBI Accession
- NM_015367, NP_056182
- UniProt
- Q9BXK5
-
Vous êtes ici:
